| Literature DB >> 33842378 |
Weiqi Zhang1,2, Wen Zhu1,2, Jian Yang1,2, Nan Xiang1,2, Ning Zeng1,2, Haoyu Hu1,2, Fucang Jia3, Chihua Fang1,2.
Abstract
BACKGROUND: Accurate determination of intrahepatic anatomy remains challenging for laparoscopic anatomical hepatectomy (LAH). Laparoscopic augmented reality navigation (LARN) is expected to facilitate LAH of primary liver cancer (PLC) by identifying the exact location of tumors and vessels. The study was to evaluate the safety and effectiveness of our independently developed LARN system in LAH of PLC.Entities:
Keywords: anatomical hepatectomy; augmented reality; laparoscopic surgical navigation; primary liver cancer; three-dimensional laparoscopy
Year: 2021 PMID: 33842378 PMCID: PMC8027474 DOI: 10.3389/fonc.2021.663236
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 6.244
Figure 13D LARN software interface.
Patient Characteristics.
| Characteristics | IN group (n = 44) | NIN group (n = 41) |
|
|---|---|---|---|
|
| |||
| Age, year, median (range) | 53 (25-74) | 61 (26-78) | 0.381 |
| Sex, n (%) | 0.659 | ||
| Male | 36 (82) | 35 (85) | |
| Female | 8 (18) | 6 (15) | |
| BMI, kg/m2, median (range) | 22.3 (17.4-27.2) | 22.1 (15.4-29.0) | 0.907 |
| Hepatitis B, n (%) | 34 (77) | 25 (61) | 0.103 |
| Liver cirrhosis, n (%) | 21 (48) | 13 (32) | 0.132 |
| Child-Pugh classification, n (%) | 0.738 | ||
| Class A | 40 (91) | 39 (95) | |
| Class B | 4 (9) | 2 (5) | |
|
| |||
| AFP, ng/mL, median (range) | 10.1 (1.6-79776.0) | 10.7 (1.4-166690.0) | 0.076 |
| CA19-9, U/mL, median (range) | 16.6 (1.1-968.6) | 27.5 (0.6-431800.0) | 0.208 |
| TBil, mg/dL, median (range) | 0.8 (0.4-2.4) | 0.9 (0.3-8.9) | 0.208 |
| Hb, g/L, median (range) | 137 (97-170) | 135 (99-185) | 0.264 |
| ALB, g/L, median (range) | 37.8 (28.0-59.7) | 39.5 (27.3-52.9) | 0.335 |
| PLT, 103/μL, median (range) | 177 (14-469) | 220 (30-539) | 0.418 |
|
| |||
| Tumor size | 6.0 (0.6-16.0) | 7.0 (1.3-18.0) | 0.779 |
| Tumor number, n (%) | |||
| Solitary | 41 (93) | 38 (93) | 1.000 |
| 2-3 nodules | 3 (7) | 2 (5) | 1.000 |
| >3 nodules | 0 | 1 (2) | 0.482 |
| Anatomical resection, n (%) | |||
| Left hepatectomy (S2, S3 and S4) | 10 (23) | 11 (27) | 0.661 |
| Right hepatectomy (S5, S6, S7 and S8) | 19 (44) | 15 (36) | 0.535 |
| Left lateral sectionectomy (S2+3) | 2 (4) | 6 (15) | 0.222 |
| Mesohepatectomy (S4, S5 and S8) | 4 (9) | 3 (7) | 1.000 |
| Right posterior sectionectomy (S6+7) | 7 (16) | 6 (15) | 0.870 |
| S5+6 segmentectomy | 2 (4) | 0 (0) | 0.496 |
| Extent of resection, n (%) | 0.658 | ||
| Minor | 11 (25) | 12 (29) | |
| Major | 33 (75) | 29 (71) | |
| Pathological findings, n (%) | 0.843 | ||
| Hepatocellular carcinoma | 38 (86) | 36 (88) | |
| Cholangiocarcinoma | 6 (14) | 5 (12) |
BMI, body mass index; AFP, α-fetoprotein; CA19-9, carbohydrate antigen 19-9; Hb, hemoglobin; TBil, total bilirubin; ALB, albumin; PLT, platelet.
Removal of less than 3 hepatic segments.
Removal of 3 or more adjacent hepatic segments.
Perioperative Outcomes and Recurrence Patterns.
| IN group (n = 44) | NIN group (n = 41) |
| |
|---|---|---|---|
| Operation time, min, median (range) | 300 (90-690) | 300 (90-540) | 0.061 |
| Blood loss, mL, median (range) | 200 (20-400) | 300 (50-1000) |
|
| Delta Hb% | 12.1 (1.3-34.6) | 14.1 (6.3-57.9) |
|
| Intraoperative blood transfusion, n (%) |
| ||
| Yes | 5 (10) | 19 (42) | |
| No | 39 (90) | 22 (58) | |
| Resection-related complications, n (%) | |||
| Total | 18 (41) | 19 (46) | 0.614 |
| Wound infection | 0 (0) | 1 (2) | 0.482 |
| Abdominal hemorrhage | 0 (0) | 1 (2) | 0.482 |
| Lung infection | 2 (5) | 3 (7) | 0.935 |
| Pleural effusion | 12 (27) | 12 (30) | 0.838 |
| Ascites | 4 (9) | 2 (5) | 0.738 |
| Liver failure | 0 (0) | 0 (0) | – |
| Clavien-Dindo classification of complications, n (%) | |||
| Grade I or II | 15 (32) | 14 (33) | 0.996 |
| ≥Grade III | 3 (7) | 5 (11) | 0.634 |
| Postoperative hospital stay, day, median (range) | 8 (4-14) | 10 (4-23) |
|
| Recurrence Patterns | |||
| Overall recurrence, n (%) | 11 (25) | 16 (39) | 0.165 |
| Intrahepatic, n (%) | 7 (16) | 12 (29) | 0.140 |
| Extrahepatic, n (%) | 1 (2) | 2 (5) | 0.950 |
| Intrahepatic and extrahepatic, n (%) | 3 (7) | 2 (5) | 1.000 |
(Difference between preoperative Hb and postoperative lowest Hb/preoperative Hb)×100.
Bold values indicate P < 0.05.
Figure 2LARN-assisted right hepatectomy. (A), enhanced CT indicated that the lesion was in the right liver, and it was closely related to the right PV. Iodide oil deposition was found inside the lesion. (B), The 3D reconstructed model showed the relationship between the lesion and hepatic vessels. (C), simulated right hepatectomy was performed, and the residual liver volume ratio was 47.1%. (D), intraoperative navigation of the right hepatic artery. (E), intraoperative navigation of the main PV and the right PV. (F), intraoperative navigation of right hepatic vein.
Figure 3LARN-assisted right posterior sectionectomy. (A), the lesion was located in the right posterior sector from 3D visualization. (B), the resected liver volume was calculated to be 340.12 ml (41.33%) based on simulated hepatectomy. (C), intraoperative navigation of the main PV and hepatic artery. (D), intraoperative navigation of the right hepatic artery. (E), the right PV was suspended under the image navigation. (F, G), the right posterior PV branch was dissected and severed with the assistance of LARN. (H), intraoperative navigation of the hepatic veins in S6 and S7.
Figure 4LARN-assisted S5+6 segmentectomy. (A), abdominal contrast-enhanced CT scan revealed a mixed density lesion in the right liver with heterogeneous enhancement. (B), the lesion was located in the S5 and S6 from 3D visualization. (C), the resected liver volume was 228.52 ml (26.57%) based on simulated hepatectomy. (D, E), 3D models were projected onto the liver surface to show the relationship between the lesion and PVs. (F), intraoperative navigation of the PV branch of S5. (G), intraoperative navigation of the PV branch of S6. (H), intraoperative navigation of middle hepatic vein.